Repare Therapeutics Inc. - Common shares, no par value (RPTX)
CUSIP: 760273102
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common shares, no par value
- Shares outstanding
- 42,837,925
- Total 13F shares
- 22,517,975
- Share change
- +22,517,875
- Total reported value
- $698,109,449
- Price per share
- $31.02
- Number of holders
- 47
- Value change
- +$698,106,449
- Number of buys
- 46
Quarterly Holders Quick Answers
What is CUSIP 760273102?
CUSIP 760273102 identifies RPTX - Repare Therapeutics Inc. - Common shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 760273102:
Top shareholders of RPTX - Repare Therapeutics Inc. - Common shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Repare Therapeutics Inc. - Common shares, no par value (RPTX) as of Q2 2020
As of 30 Jun 2020,
Repare Therapeutics Inc. - Common shares, no par value (RPTX) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,517,975 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, MPM ASSET MANAGEMENT LLC, FMR LLC, CHI Advisors LLC, MPM Oncology Impact Management LP, Redmile Group, LLC, BVF INC/IL, Logos Global Management LP, Artal Group S.A., and RA CAPITAL MANAGEMENT, L.P..
This page lists
47
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
1
Q2 2020 holders
47
Holder diff
46
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.